VENCLYXTO 10 mg, film-coated tablet 14 tablets
Active ingredients: Venetoclax
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet14 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VENCLYXTO 10 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 7 plaquette(s) PVC polyéthylène polychlortrifluoroéthylène unidose(s) de 2 comprimé(s)
- Marketing authorisation holder
- ABBVIE DEUTSCHLAND (ALLEMAGNE)
- Reimbursement according to BDPM
- 100%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Certains types de Leucémie Lymphoïde Chronique. ; JOURNAL OFFICIEL ; 12/06/18
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Feb 2017
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62598280CIP73007785CIP133400930077856Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VÉNÉTOCLAXcomprimé | 10 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.